eIF6 is potential diagnostic and prognostic biomarker that associated with (18)F-FDG PET/CT features and immune signatures in esophageal carcinoma

BACKGROUND: Although eukaryotic initiation factor 6 (eIF6) is a novel therapeutic target, data on its importance in the development of esophageal carcinoma (ESCA) remains limited. This study evaluated the correlation between eIF6 expression and metabolic analysis using fluorine-18 fluorodeoxyglucose...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yan, Yuan, Lingling, Zeng, Jing, Li, Fuyan, Li, Xiaohui, Tan, Fan, Liu, Xusheng, Wan, Huabing, Kui, Xueyan, Liu, Xiaoyu, Ke, Changbin, Pei, Zhijun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258187/
https://www.ncbi.nlm.nih.gov/pubmed/35794622
http://dx.doi.org/10.1186/s12967-022-03503-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9258187/
https://www.ncbi.nlm.nih.gov/pubmed/35794622
http://dx.doi.org/10.1186/s12967-022-03503-7

Ejemplares similares